|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genetic variation analyses by Pyrosequencing 显示文摘 | LANGAEE T RONAGHI M | 2005 | Mutation Research2005，573，： | 1 |
| 2 | Chronic pain, perceived stress, and cellular aging:An exploratory study 显示文摘 | Sibille K T Langaee T Burkley B | 2012 | Mol Pain2012，，： | 1 |
| 3 | Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements显示文摘 | Aquilante C L Langaee T Y Lopez L M | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 4 | Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil显示文摘 | LANGAEE T Y GONG Y YARANDI H N | 2007 | Clin Pharmacol Ther2007，81，3： | 1 |
| 5 | Genetic variation analyses by pyrosequencing显示文摘 | Langaee T Ronaghi M | 2005 | Mutation Research2005，573，12： | 1 |
| 6 | Rapid detection of viable Bacillus cereus emetic and enterotoxic strains in food by coupling propidium monoazide and multiplex PCR(PMA-mPCR) 显示文摘 | Forghani F Langaee T Eskandari M | 2015 | Food Control2015，，55： | 1 |
| 7 | Identificationof suitable endogenous norm alizers for qRT-PC Ranalysis of plasm a m icroRN A expression in essential hypertension显示文摘 | So laym an M H Langaee T Patel A | 2016 | Mol B iotechnol2016，58，3： | 1 |
| 8 | Influ- ence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene poly- morphisms on warfarin dose requirements 显示文摘 | Aquilante C L Langaee T Y Lopez L M | 2006 | Clin Phar- macol Ther2006，79，4： | 1 |
| 9 | A genome - wide scan for common genetic variants with a large influence on warfarin maintenance dose 显示文摘 | COOPER G M JOHNSON J A LANGAEE T Y | 2008 | Blood2008，112，4： | 1 |
| 10 | In- fluence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements * 显示文摘 | AQUILANTE C L LANGAEE T Y LOPEZ L M | 2006 | Clin Pharrn Ther2006，79，4： | 1 |
| 11 | Influence ofcoagulation factor,vitamin K epoxide reductase complex sub-unit 1, and cytochrome P450 2C9 gene polymorphisms onwarfarin dose requirements显示文摘 | Aquilante C L Langaee T Y Lopez L M | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 12 | Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements 显示文摘 | Aquilante C L Langaee T Y Lopez L M | 2006 | Clin Pharmacol Ther2006，79，4： | 1 |
| 13 | A ge- nome-wide scan for common genetic variants with a large influence on warfarin maintenance dose显示文摘 | Cooper G M Johnson J A Langaee T Y | 2008 | Blood2008，112，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员